Periprosthetic bone loss post-total hip arthroplasty mitigated by bisphosphonate therapy
How to Cite
OrthoEvidence. Periprosthetic bone loss post-total hip arthroplasty mitigated by bisphosphonate therapy. ACE Report. 2019;8(2):122. Available from: https://myorthoevidene.com/AceReport/Report/10776
Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysisJ Orthop Surg Res. 2018 Sep 4;13(1):225. doi: 10.1186/s13018-018-0918-7
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
12 randomized controlled trials were included in this meta-analysis which sought to evaluate the effect of bisphosphonate therapy in reducing loss of periprosthetic bone mineral density after total hip arthroplasty. In pooled analyses, reduction of periprosthetic bone mineral density was smaller among BP groups compared to control groups within 1 year of surgery, at 2-4 years after surgery, and at...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE